NCM Capital Management’s Merck MRK Stock Holding History

NCM Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.37M	Buy	18,441 +1,054	+6%	+$123K	0.73%	32
2026 Q1	$2.09M	Sell	17,387 -612	-3%	-$70.7K	0.75%	27
2025 Q4	$1.89M	Sell	17,999 -609	-3%	-$57.2K	0.7%	28
2025 Q3	$1.56M	Buy	18,608 +17	+0.1%	+$1.4K	0.61%	39
2025 Q2	$1.47M	Hold	18,591	–	–	0.6%	37
2025 Q1	$1.67M	Hold	18,591	–	–	0.75%	28
2024 Q4	$1.85M	Buy	18,591 +98	+0.5%	+$10.1K	0.83%	24
2024 Q3	$2.1M	Buy	18,493 +300	+2%	+$35.6K	1.01%	20
2024 Q2	$2.25M	Buy	18,193 +1,638	+10%	+$211K	1.18%	16
2024 Q1	$2.18M	Hold	16,555	–	–	1.22%	16
2023 Q4	$1.8M	Hold	16,555	–	–	1.09%	20
2023 Q3	$1.7M	Sell	16,555 -150	-0.9%	-$16.2K	1.21%	18
2023 Q2	$1.93M	Hold	16,705	–	–	1.34%	16
2023 Q1	$1.78M	Sell	16,705 -400	-2%	-$43.2K	1.33%	15
2022 Q4	$1.9M	Hold	17,105	–	–	1.25%	15
2022 Q3	$1.47M	Hold	17,105	–	–	1.11%	18
2022 Q2	$1.56M	Hold	17,105	–	–	1.09%	25
2022 Q1	$1.4M	Buy	17,105 +456	+3%	+$36K	0.88%	32
2021 Q4	$1.28M	Buy	+16,649	New	+$1.33M	1.13%	23

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

NCM Capital Management's MRK Position: Q2 2026 in Review

NCM Capital Management increased its Merck (MRK) stake by 6.1% in Q2 2026, buying an estimated $123K and bringing the position to 18,441 shares worth $2.37M. The position accounts for 0.73% of the portfolio, ranked #32.

NCM Capital Management first reported a position in MRK in Q4 2021 and has held it in 19 quarters since. 3,844 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

NCM Capital Management held 18,441 shares of Merck worth $2.37M as of Q2 2026.
NCM Capital Management bought 1,054 Merck shares in Q2 2026, an estimated $123K.
Merck made up 0.73% of NCM Capital Management's portfolio in Q2 2026, its #32 holding.
NCM Capital Management first reported a position in Merck in Q4 2021 and has held it in 19 quarters since.
3,844 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on NCM Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.